首页> 外文OA文献 >Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
【2h】

Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS

机译:包含saRs-CoV病毒核苷酸序列的遗传修饰植物及其用于免疫saRs的方法

摘要

The invention relates to genetically modified plants and progeny thereof which constitute edible plant-derived mucosal vaccines and injectable plant-derived mucosal vaccines against Severe Acute Respiratory Syndrome (SARS). The invention relates to a recombinant vector that transforms specifically, but not limited to, the nuclei and/or plastids of tobacco, tomato and lettuce plants for antigen production. In specific embodiments, the plastid transformation vector expressing the nucleotide sequences are pCV1, pCV6 and pCV8, and their derivatives containing an S1 with nucleotide (but not amino acid) changes to optimize codon usage for expression in plants.; The present invention relates to methods of making the modified plants which comprises transformation of plants with vectors for nuclearexpression and/or plastid expression of nucleotide sequences of the SARS-CoV virus, fragments, derivatives, analogs, or variants thereof. The present invention also relates to methods of immunizationagainst SARS and methods of antibody detection using the SARS-CoV antigens generated by the plastid and/or nuclear vector(s) transformed plants.
机译:本发明涉及转基因植物及其后代,其构成了可食用的植物来源的粘膜疫苗和可注射的植物来源的粘膜疫苗,以抵抗严重急性呼吸系统综合症(SARS)。本发明涉及重组载体,其特异性地转化但不限于用于抗原生产的烟草,番茄和莴苣植物的核和/或质体。在特定的实施方案中,表达核苷酸序列的质体转化载体是pCV1,pCV6和pCV8,并且它们的包含具有核苷酸(而不是氨基酸)的S1的衍生物改变以优化在植物中表达的密码子使用。本发明涉及制备修饰植物的方法,该方法包括用用于SARS-CoV病毒的核苷酸序列的核表达和/或质体表达的载体,其片段,衍生物,类似物或变体的植物转化。本发明还涉及针对SARS的免疫方法和使用由质体和/或核载体转化的植物产生的SARS-CoV抗原的抗体检测方法。

著录项

  • 作者

  • 作者单位
  • 年度 2007
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号